BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Argus Health
Queensland Health
Express Scripts
Boehringer Ingelheim

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019481

« Back to Dashboard

NDA 019481 describes RENACIDIN, which is a drug marketed by United Guardian and is included in one NDA. It is available from one supplier. Additional details are available on the RENACIDIN profile page.

The generic ingredient in RENACIDIN is citric acid; gluconolactone; magnesium carbonate. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the citric acid; gluconolactone; magnesium carbonate profile page.

Summary for 019481

Formulation / Manufacturing:see details

Pharmacology for NDA: 019481

Suppliers and Packaging for NDA: 019481

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RENACIDIN citric acid; gluconolactone; magnesium carbonate SOLUTION;IRRIGATION 019481 NDA United-Guardian, Inc. 0327-0011 0327-0011-05 500 mL in 1 BOTTLE (0327-0011-05)
RENACIDIN citric acid; gluconolactone; magnesium carbonate SOLUTION;IRRIGATION 019481 NDA United-Guardian, Inc. 0327-0012 0327-0012-30 30 BOTTLE in 1 CARTON (0327-0012-30) > 30 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IRRIGATIONStrength6.602GM/100ML;198MG/100ML;3.177GM/100ML
Approval Date:Oct 2, 1990TE:RLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: